Rosa Coll
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Hematology 28
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 4
- Hematopoietic Stem Cell Transplantation 3
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- Montserrat Arnán (6 shared papers)Lurdes Zamora (6 shared papers)O. García-García (5 shared papers)Olga Salamero (3 shared papers)Susana Vives (3 shared papers)David Gallardo (3 shared papers)Blanca Xicoy (5 shared papers)Francesc Gessé Solé (3 shared papers)
- Journals
- Blood (6 papers)HemaSphere (4 papers)Leukemia Research (3 papers)British Journal of Haematology (3 papers)Blood Cancer Journal (3 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Rosa Coll
40 papers receiving 636 citations
Peers
Comparison fields: 5 of 40
- Hematology 318
- Infectious Diseases 104
- Public Health, Environmental and Occupational Health 137
- Oncology 76
- Genetics 20
Countries citing papers authored by Rosa Coll
This map shows the geographic impact of Rosa Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Coll more than expected).
Fields of papers citing papers by Rosa Coll
This network shows the impact of papers produced by Rosa Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Coll. The network helps show where Rosa Coll may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosa Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 121 | |
| 2 | 2020 | 68 | |
| 3 | 2020 | 38 | |
| 4 | 2021 | 38 | |
| 5 | 2013 | 28 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 28 | |
| 8 | 2016 | 26 | |
| 9 | 2020 | 21 | |
| 10 | 2021 | 18 | |
| 11 | 2011 | 17 | |
| 12 | 2015 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2023 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 13 | |
| 17 | 2017 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2024 | 11 |
About Rosa Coll
Rosa Coll is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Oncology and Pathology and Forensic Medicine, having authored 44 papers that have together received 641 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (318 citations), Infectious Diseases (104 citations), Public Health, Environmental and Occupational Health (137 citations), Oncology (76 citations) and Genetics (20 citations). Rosa Coll has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Montserrat Arnán, Lurdes Zamora, O. García-García, Olga Salamero, Susana Vives, David Gallardo, Blanca Xicoy, Francesc Gessé Solé, Jorge Sierra Gil and Antoni García‐Guiñón. Their work appears in journals such as Blood, HemaSphere, Leukemia Research, British Journal of Haematology and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.